期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Prediction of Smear Positive TB Cases at Different Types of Designated Microscopy Centres, Karnataka, India
1
作者 Sharath Burugina Nagaraja Suresh Shastri +4 位作者 Jaya Prasad Tripathy Ghansham Sharma Shilpashree Madhav Kunjathur anil singarajipur Sarabjit Chadha 《Journal of Tuberculosis Research》 2017年第4期258-264,共7页
Background: Under the Revised National Tuberculosis control Programme (RNTCP) in India, the designated microscopy centres (DMCs) form the basic unit of smear positive TB case detection in a district. There is a need b... Background: Under the Revised National Tuberculosis control Programme (RNTCP) in India, the designated microscopy centres (DMCs) form the basic unit of smear positive TB case detection in a district. There is a need by the programme managers to estimate the mean and range of smear positive tuberculosis (TB) cases that can be detected at DMCs located in different type of health facilities to channelize their resources. Methods: It is a cross-sectional study conducted in the state of Karnataka, India during January 2014 to December 2014 based on the compiled reports from past five years received from all the 30 districts of the state. The prediction was made based on the performance of these DMCs in the last five years using a modeling technique. Results: The proportions of the DMCs located at health facilities are Primary Health Institutions/Centres (PHIs)—73%, Tuberculosis Units (TUs)—15%, Medical colleges (MC)—7%, District TB centres (DTC)—3% and Private Practitioners (PP)—2%. The maximum number of cases that can be detected at DTC is 3621 (SD 54), TU is 9224 (SD 90), PHI is 20,412 (SD 135), PP is 859 (SD 26) and MC is 8322 (SD 84). Conclusion: The predicted values will essentially serve as a tool for the programme managers of Karnataka to plan, strategize and monitor the performance of DMCs in the state. 展开更多
关键词 Normal Probability Model SMEAR POSITIVE TB PREDICTION INDIA
下载PDF
“Kill-TB” Drug Reminder Mobile Application for Tuberculosis Patients at Bengaluru, India: Effectiveness and Challenges
2
作者 Sharath Burugina Nagaraja Naveen Kotur +5 位作者 Niranjan Murthy Shilpashree Madhava Kunjathur Nanda Sappandi Deepak Murthy Arundathi Das anil singarajipur 《Journal of Tuberculosis Research》 2020年第1期1-10,共10页
Background: Tuberculosis remains a major public health problem in India. Newer digital technologies for treatment adherence have been tested for diseases with chronic medication. A mobile application (Kill-TB) that pr... Background: Tuberculosis remains a major public health problem in India. Newer digital technologies for treatment adherence have been tested for diseases with chronic medication. A mobile application (Kill-TB) that provides reminder to TB patients through alarm was tested for its effectiveness and challenges under programmatic settings. Methods: A cohort of TB patients initiated on treatment with and without mobile application at Bangalore city during January-March 2019 was observed for missed doses during their treatment period. Results: A total of 694 patients (347 patients with and without mobile application) were enrolled for the study. Among the patients with and without mobile application 1) loss to follow-up was 2% and 8%, 2) non-adherence rate to TB treatment was 1.5 and 3.3 per 100 person-months, 3) treatment success rate was 89% and 81%. Conclusion: The TB drug reminder mobile application benefits the patient’s treatment adherence and paves way for improved treatment outcomes despite the challenges in implementation. The programme should leverage mobile technologies as an additional monitoring tool to achieve the target of End-TB by 2025. 展开更多
关键词 Kill-TB TUBERCULOSIS INDIA Mobile Application
下载PDF
When Does Drug Resistant TB Strike HIV/TB Patients?—A South India Experience
3
作者 Suresh Shastri Sharath Burugina Nagaraja +2 位作者 Jaya Prasad Tripathy anil singarajipur Bharat Bhushan Rewari 《World Journal of AIDS》 2017年第1期34-39,共6页
Background: India is a high TB (tuberculosis) burden country. The advent of HIV (Human immunodeficiency virus) and DR-TB (drug resistant TB) has worsened the ongoing TB control efforts. A study was conducted to (a) to... Background: India is a high TB (tuberculosis) burden country. The advent of HIV (Human immunodeficiency virus) and DR-TB (drug resistant TB) has worsened the ongoing TB control efforts. A study was conducted to (a) to determine the duration for developing drug resistant TB after diagnosis of HIV (b) to ascertain the patients status after one year of DR-TB treatment in Karnataka, India. Methods: It is a retrospective cross-sectional study involving review of records and reports at ART (Anti-retroviral treatment) centres and DR-TB centres in Karnataka during the period 2013-2014. Results: The median time from being known as HIV positive to being diagnosed as DR-TB was 1168 days (IQR: 571 - 1955). At the end of 14 months, nearly 39% of patients had died and 49% of patients were on treatment. Conclusion: The National Health programmes should prioritize monitoring of the HIV/TB patients and develop appropriate novel strategies for community involvement. 展开更多
关键词 HIV DR-TB OUTCOMES DURATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部